COSMOS Pharmaceutical Corp.

  • Market Cap: Mid Cap
  • Industry: Retailing
  • ISIN: JP3298400007
  • TKS: 3349
JPY
6,436.00
-207 (-3.12%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
May'26
Feb'26
Nov'25
Aug'25
May'25
Feb'25
Nov'24
Net Sales
2,89,203.00
2,73,205.00
2,64,781.00
2,72,394.00
2,59,122.00
2,46,332.00
2,44,095.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,89,203.00
2,73,205.00
2,64,781.00
2,72,394.00
2,59,122.00
2,46,332.00
2,44,095.00
Raw Material Cost
2,29,461.00
2,16,146.00
2,09,074.00
2,15,219.00
2,05,049.00
1,93,198.00
1,92,584.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
257.00
107.00
107.00
110.00
109.00
48.00
48.00
Selling and Distribution Expenses
49,411.00
45,714.00
46,676.00
45,529.00
45,297.00
41,850.00
42,748.00
Other Expenses
-25.70
-10.70
-10.70
-11.00
-10.90
-4.80
-4.80
Total Expenditure (Excl Depreciation)
2,78,872.00
2,61,860.00
2,55,750.00
2,60,748.00
2,50,346.00
2,35,048.00
2,35,332.00
Operating Profit (PBDIT) excl Other Income
10331
11345
9031
11646
8776
11284
8763
Other Income
638.00
642.00
752.00
578.00
592.00
655.00
645.00
Operating Profit (PBDIT)
17,584.00
18,229.00
15,754.00
17,972.00
15,381.00
17,569.00
14,808.00
Interest
257.00
107.00
107.00
110.00
109.00
48.00
48.00
Exceptional Items
-114.00
78.00
-103.00
-25.00
-75.00
-148.00
16.00
Gross Profit (PBDT)
59,742.00
57,059.00
55,707.00
57,175.00
54,073.00
53,134.00
51,511.00
Depreciation
6,615.00
6,242.00
5,971.00
5,748.00
6,013.00
5,630.00
5,400.00
Profit Before Tax
10,597.00
11,958.00
9,575.00
12,088.00
9,186.00
11,743.00
9,377.00
Tax
1,299.00
3,858.00
3,098.00
3,916.00
551.00
3,828.00
3,092.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
9,298.00
8,100.00
6,477.00
8,171.00
8,635.00
7,915.00
6,285.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
9,298.00
8,100.00
6,477.00
8,171.00
8,635.00
7,915.00
6,285.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
9,298.00
8,100.00
6,477.00
8,171.00
8,635.00
7,915.00
6,285.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,83,700.00
2,74,255.00
2,69,131.00
2,62,658.00
2,57,463.00
2,48,822.00
2,43,486.00
Earnings per share (EPS)
117.31
102.2
81.72
103.09
108.95
99.86
79.3
Diluted Earnings per share
117.31
102.2
81.72
103.09
108.95
99.86
79.3
Operating Profit Margin (Excl OI)
3.57%
4.15%
3.41%
4.28%
3.39%
4.58%
3.59%
Gross Profit Margin
5.95%
6.66%
5.87%
6.55%
5.87%
7.05%
6.05%
PAT Margin
3.22%
2.96%
2.45%
3.0%
3.33%
3.21%
2.57%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended May 2026 is 9.22%

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended May 2026 is 43.55%

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended May 2026 is 12.96%

stock-summary

Interest

QoQ Growth in quarter ended May 2026 is 140.19%

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended May 2026 has improved from Nov 2025

Compare Quarterly Results Of COSMOS Pharmaceutical Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
2,89,203.00
3,44,365.00
-55,162.00
-16.02%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,89,203.00
3,44,365.00
-55,162.00
-16.02%
Raw Material Cost
2,29,461.00
2,38,132.00
-8,671.00
-3.64%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
257.00
211.00
46.00
21.80%
Selling and Distribution Expenses
49,411.00
91,235.00
-41,824.00
-45.84%
Other Expenses
-25.70
-21.10
-4.60
-21.80%
Total Expenditure (Excl Depreciation)
2,78,872.00
3,29,367.00
-50,495.00
-15.33%
Operating Profit (PBDIT) excl Other Income
10,331.00
14,998.00
-4,667.00
-31.12%
Other Income
638.00
1,429.00
-791.00
-55.35%
Operating Profit (PBDIT)
17,584.00
23,030.00
-5,446.00
-23.65%
Interest
257.00
211.00
46.00
21.80%
Exceptional Items
-114.00
-286.00
172.00
60.14%
Gross Profit (PBDT)
59,742.00
1,06,233.00
-46,491.00
-43.76%
Depreciation
6,615.00
6,603.00
12.00
0.18%
Profit Before Tax
10,597.00
15,930.00
-5,333.00
-33.48%
Tax
1,299.00
6,007.00
-4,708.00
-78.38%
Provisions and contingencies
0
0
0.00
Profit After Tax
9,298.00
9,822.00
-524.00
-5.33%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
9,298.00
9,822.00
-524.00
-5.33%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
101.00
-101.00
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
9,298.00
9,923.00
-625.00
-6.30%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
2,83,700.00
2,62,103.00
21,597.00
8.24%
Earnings per share (EPS)
117.31
47.24
70.07
148.33%
Diluted Earnings per share
117.31
47.24
70.07
148.33%
Operating Profit Margin (Excl OI)
3.57%
4.36%
0.00
-0.79%
Gross Profit Margin
5.95%
6.54%
0.00
-0.59%
PAT Margin
3.22%
2.85%
0.00
0.37%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 28,920.30 Million
in May 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2026 is 9.22%

stock-summary

YoY Growth in quarter ended May 2026 is 11.61% vs 3.78% in May 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 929.80 Million
in May 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2026 is 43.55%

stock-summary

YoY Growth in quarter ended May 2026 is 7.68% vs 21.67% in May 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,694.60 Million
in May 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2026 is 12.96%

stock-summary

YoY Growth in quarter ended May 2026 is 14.59% vs 12.16% in May 2025

Quarterly - Interest
Interest 25.70 Million
in May 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2026 is 140.19%

stock-summary

YoY Growth in quarter ended May 2026 is 135.78% vs 136.96% in May 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.57%
in May 2026

Figures in %
stock-summary

QoQ Growth in quarter ended May 2026 has improved from Nov 2025

stock-summary

YoY Growth in quarter ended May 2026 has improved from May 2025

Footer loading
COSMOS Pharmaceutical Corp. Quarterly Results: Standalone & Consolidated Reports | Analysis & Trends (15 Years)